J. P. Devogelaer

Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis

J. P. Devogelaer, H Bröll, R Correa-Rotter et al. · Bone · 1996 · 190 citations

Bone Disease, Orthopaedic Surgery, Oral Alendronate Induces +8

Intravertebral vacuum cleft: changes in content after supine positioning.

Jacques Malghem, B. Maldague, M A Labaisse et al. · Radiology · 1993 · 159 citations

Vacuum Cleft, Magnetic Resonance, Diagnosis +19

Prevention of Bone Loss with Risedronate in Glucocorticoid-Treated Rheumatoid Arthritis Patients

Richard Eastell, J. P. Devogelaer, Nicola Peel et al. · Osteoporosis International · 2000 · 133 citations

Bone Disease, Rheumatology, Bone Loss +7

Comparative prospective, double‐blind, multicenter study of the efficacy of tiludronate and etidronate in the treatment of paget's disease of bone

Christian Roux, C. Gennari, Jordi Farrerons et al. · Arthritis & Rheumatism · 1995 · 123 citations

Low bone mass in hypogonadal males. Effect of testosterone substitution therapy, a densitometric study

J. P. Devogelaer, Serge de Cooman, C Nagant de Deuxchaisnes · Maturitas · 1992 · 102 citations

Bone Disease, Densitometric Study, Andrology +10